Unknown

Dataset Information

0

Detrimental effects of diet-induced obesity on ? pathology are independent of insulin resistance in ? transgenic mice.

ABSTRACT: The ? pathology found in Alzheimer disease (AD) is crucial in cognitive decline. Midlife development of obesity, a major risk factor of insulin resistance and type 2 diabetes, increases the risk of dementia and AD later in life. The impact of obesity on AD risk has been suggested to be related to central insulin resistance, secondary to peripheral insulin resistance. The effects of diet-induced obesity (DIO) on ? pathology remain unknown. In this study, we evaluated effects of a high-fat diet, given at an early pathological stage, in the THY-Tau22 transgenic mouse model of progressive AD-like ? pathology. We found that early and progressive obesity potentiated spatial learning deficits as well as hippocampal ? pathology at a later stage. Surprisingly, THY-Tau22 mice did not exhibit peripheral insulin resistance. Further, pathological worsening occurred while hippocampal insulin signaling was upregulated. Together, our data demonstrate that DIO worsens ? phosphorylation and learning abilities in ? transgenic mice independently from peripheral/central insulin resistance.

SUBMITTER: Leboucher A 

PROVIDER: S-EPMC3636620 | biostudies-literature | 2013 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The τ pathology found in Alzheimer disease (AD) is crucial in cognitive decline. Midlife development of obesity, a major risk factor of insulin resistance and type 2 diabetes, increases the risk of dementia and AD later in life. The impact of obesity on AD risk has been suggested to be related to central insulin resistance, secondary to peripheral insulin resistance. The effects of diet-induced obesity (DIO) on τ pathology remain unknown. In this study, we evaluated effects of a high-fat diet, g  ...[more]

Similar Datasets

Unknown Augmented Insulin and Leptin Resistance of High Fat Diet-Fed APPswe/PS1dE9 Transgenic Mice Exacerbate Obesity and Glycemic Dysregulation.
| S-EPMC6121904 | biostudies-other
Unknown Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice.
| S-EPMC3700412 | biostudies-literature
Unknown Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice.
| S-EPMC7224297 | biostudies-literature
Unknown PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice.
| S-EPMC3661619 | biostudies-other
Unknown A post-weaning obesogenic diet exacerbates the detrimental effects of maternal obesity on offspring insulin signaling in adipose tissue.
| S-EPMC5364470 | biostudies-literature
Unknown Adipocyte-specific CD1d-deficiency mitigates diet-induced obesity and insulin resistance in mice.
| S-EPMC4916414 | biostudies-literature
Unknown Vimentin Deficiency Prevents High-Fat Diet-Induced Obesity and Insulin Resistance in Mice.
| S-EPMC7850873 | biostudies-literature
Unknown Loss of mitochondrial protease ClpP protects mice from diet-induced obesity and insulin resistance.
| S-EPMC5836096 | biostudies-literature
Unknown CREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance.
| S-EPMC5411056 | biostudies-literature
Unknown Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance.
| S-EPMC4867314 | biostudies-literature